Research Estimates Long Covid to Cost OECD Economies Up to $135 Billion Annually Over Next Decade

New research indicates that long Covid may generate economic costs of up to $135 billion per year across Organisation for Economic Co-operation and Development (OECD) member countries over the next decade. This projection comes as the acute phase of the Covid-19 pandemic has subsided.

The study, reported by @business, focuses on the persistent health effects of the virus on individuals and broader economic implications.

Long Covid refers to symptoms that continue or develop after the initial infection, affecting millions worldwide. OECD economies encompass 38 member nations, including major players like the United States, Japan, and Germany. The research underscores how these lingering health issues could strain labor markets and public health resources.

The estimated $135 billion annual cost accounts for factors such as lost productivity, increased healthcare expenditures, and reduced workforce participation.

Researchers analyzed data from post-pandemic recovery trends in OECD countries. The figure represents a potential upper bound, based on current prevalence rates of long Covid. Affected groups include workers experiencing fatigue, cognitive difficulties, and other symptoms that limit employment.

Healthcare systems in OECD nations may face sustained demand for treatments and support services. Businesses could encounter higher absenteeism and recruitment challenges as a result.

The Covid-19 pandemic, which began in early 2020, led to widespread infections and lockdowns across OECD economies.

While vaccination campaigns and public health measures have reduced severe cases, long Covid remains a concern for public policy. Governments and international organizations like the OECD are monitoring these developments to inform recovery strategies. Next steps may involve enhanced research funding, workplace accommodations, and policy adjustments to mitigate economic losses.

The OECD could release further reports on integrating long Covid considerations into economic planning. Ongoing studies will track prevalence and costs to refine these estimates.